Table: Zeria Pharm - 9-MTH group results

Zeria Pharmaceutical

02/02/2023 07:00

Feb 2 (Reuters)- 
             Zeria Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2022        Dec 31, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             51.73               45.10            66.00    
                 (+14.7 pct)         (+11.7 pct)      (+10.9 pct) 
  Operating          8.55                5.50             7.00    
                 (+55.6 pct)         (+41.6 pct)      (+10.0 pct) 
  Recurring          6.96                5.61             7.00    
                 (+24.0 pct)         (+57.6 pct)      (+17.9 pct) 
  Net                5.98                4.04             5.60    
                 (+47.9 pct)         (+9.2 pct)       (+41.4 pct) 
  EPS            135.31 yen           89.33 yen       126.74 yen  
  Ann Div                             35.00 yen        38.00 yen  
  -Q2 div         18.00 yen           17.00 yen                   
  -Q4 div                             18.00 yen        20.00 yen  
  
  NOTE - Zeria Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T